Quazolast
CAS No. 86048-40-0
Quazolast( —— )
Catalog No. M34121 CAS No. 86048-40-0
Quazolast (RHC 3988) is a potent mediator release inhibitor used as a control against ragweed antigenic nasal challenge and demonstrates superiority over placebo in preventing nasal congestion and nasal itching following such challenges.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 342 | In Stock |
|
| 10MG | 504 | In Stock |
|
| 25MG | 816 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1479 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2967 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameQuazolast
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuazolast (RHC 3988) is a potent mediator release inhibitor used as a control against ragweed antigenic nasal challenge and demonstrates superiority over placebo in preventing nasal congestion and nasal itching following such challenges.
-
DescriptionQuazolast (RHC 3988) is a potent mediator release inhibitor used as a control against ragweed antigenic nasal challenge and demonstrates superiority over placebo in preventing nasal congestion and nasal itching following such challenges.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number86048-40-0
-
Formula Weight262.65
-
Molecular FormulaC12H7ClN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(OC)(=O)C=1OC=2C=3C(C(Cl)=CC2N1)=CC=CN3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MLC - derived peptid...
MLC - derived peptide
-
NUC-7738
NUC-7738 is a 5'-aryloxyphosphoamidate prodrug of 3'-dA that reduces β-catenin nuclear expression in AML cells, modulates β-catenin signaling, and can be used in cancer research.
-
[Tyr0] - α - CGRP, [...
[Tyr0] - α - CGRP, [Tyr0] - α - CGRP, rat
Cart
sales@molnova.com